Retatrutide Research Peptide

Product Description

Retatrutide  is a synthetic research peptide classified as a triple receptor agonist targeting the GLP-1 receptor (GLP-1R), GIP receptor (GIPR), and glucagon receptor (GCGR).

Designed as a multi-target peptide compound, Retatrutide is widely studied in molecular biology, receptor pharmacology, and metabolic signaling research. Its unique triple receptor activity profile distinguishes it from single-target GLP-1 receptor agonists and dual receptor agonists such as Tirzepatide.

Retatrutide is supplied as a research-grade lyophilized peptide powder intended for laboratory research applications, including receptor interaction studies, peptide characterization, and investigations involving metabolic pathways.

Research Overview

Retatrutide is a synthetic peptide compound consisting of 39 amino acids and is investigated as a triple G protein-coupled receptor (GPCR) agonist.

The peptide targets three major receptor pathways:

• GLP-1 Receptor (GLP-1R)
• GIP Receptor (GIPR)
• Glucagon Receptor (GCGR)

This triple receptor activation profile provides researchers with a valuable tool for studying complex peptide-receptor interactions, metabolic signaling pathways, and receptor pharmacology.

Compared with traditional single receptor agonists and dual receptor agonists, Retatrutide represents an advanced research model for investigating multi-receptor peptide activity.

Mechanism of Action (Research Focus)

Retatrutide is studied for its activity across three major receptor pathways:

GLP-1 Receptor (GLP-1R)

Research involving GLP-1R focuses on:

• Glucose-dependent signaling pathways
• Insulin secretion mechanisms
• Gastrointestinal signaling regulation
• Peptide receptor interactions

GIP Receptor (GIPR)

Research involving GIPR includes:

• Incretin receptor signaling
• Cellular response pathways
• Metabolic regulation studies
• Interaction between GIP and GLP-1 signaling pathways

Glucagon Receptor (GCGR)

GCGR activation is investigated in relation to:

• Hepatic metabolic signaling
• Energy metabolism pathways
• Lipid metabolism research
• Receptor pharmacology studies

Research Applications

Retatrutide Research Peptide is commonly used in studies related to:

• Peptide receptor signaling
• Molecular biology research
• Metabolic pathway investigation
• GLP-1/GIP/glucagon receptor studies
• Receptor pharmacology
• Peptide structure and activity analysis
• Cellular signaling research

Product Information

Storage Information

• Store lyophilized peptide under recommended laboratory storage conditions.
• Protect from moisture, direct light, and excessive temperature exposure.
• Avoid repeated freeze-thaw cycles.

Research Use Statement

Retatrutide Research Peptide is supplied strictly for scientific research and laboratory use only.

This product is not intended for:

• Human consumption
• Medical or therapeutic applications
• Diagnostic use
• Veterinary use

Purchasers are responsible for ensuring compliance with applicable regulations and institutional research requirements.

FAQ

What is Retatrutide?

Retatrutide is a synthetic research peptide studied as a triple receptor agonist targeting GLP-1R, GIPR, and GCGR pathways. It is primarily investigated in peptide research, receptor signaling studies, and metabolic research applications.

What is the difference between Retatrutide and Tirzepatide?

Tirzepatide is a dual receptor agonist targeting GIP and GLP-1 receptors.

Retatrutide expands the receptor profile by additionally targeting the glucagon receptor (GCGR), creating a triple receptor agonist research model.